Abstract
The effect of SGLT-2 inhibitor switching from TZD with triple combination treatment in type 2 diabetes
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have